Dismiss this notification
PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected.
Please update your browser
for more security and a better experience.
Ivacaftor is intended for the treatment of patients with a certain mutation causing cystic fibrosis. The mutation causes about 4-6% of cases and the drug is intended to treat the underlying cause of the disease rather than symptoms.
